{
  "ticker": "SHL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964691",
  "id": "02964691",
  "pages": 6,
  "price_sensitive": false,
  "date": "20250701",
  "time": "1737",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06lbvk70b94sh4.pdf",
  "summary": "- **Type of Announcement**: Application for quotation of new securities (issued for non-cash consideration)  \n- **Security Details**:  \n  - **Code**: SHL (Ordinary Fully Paid)  \n  - **Number Issued**: 13,833,980  \n  - **Issue Date**: 01/07/2025  \n- **Purpose**: Shares issued as part consideration for the acquisition of LADR-Laboratory Group Dr. Kramer & Colleagues (per Appendix 3B dated 09/12/24).  \n- **Estimated Value per Security**: AUD 26.291600  \n- **Post-Issue Capital**:  \n  - Total Ordinary Shares on Issue: 494,237,953  \n  - Unquoted Securities: Options (SHLAM, SHLAK) and Performance Rights (SHLAZ) disclosed.  \n\n*Note: No new capital raised; transactional issuance only.*",
  "usage": {
    "prompt_tokens": 1420,
    "completion_tokens": 190,
    "total_tokens": 1610,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-01T08:02:01.837057"
}